These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 35480)

  • 21. Partial response to antipsychotic treatment: the patient with enduring symptoms.
    Emsley RA
    J Clin Psychiatry; 1999; 60 Suppl 23():10-3. PubMed ID: 10625194
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of metabolic syndrome in patients with psychotic disorders in the Netherlands.
    Schorr SG; Slooff CJ; Bruggeman R; Taxis K
    J Clin Psychopharmacol; 2009 Aug; 29(4):399-402. PubMed ID: 19593188
    [No Abstract]   [Full Text] [Related]  

  • 23. Quetiapine, a novel antipsychotic: experience in elderly patients with psychotic disorders. Seroquel Trial 48 Study Group.
    McManus DQ; Arvanitis LA; Kowalcyk BB
    J Clin Psychiatry; 1999 May; 60(5):292-8. PubMed ID: 10362435
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MJ 9022: correlation between neuroleptic potential and stereotypy.
    Sathananthan GL; Sanghvi I; Phillips N; Gershon S
    Curr Ther Res Clin Exp; 1975 Nov; 18(5):701-5. PubMed ID: 1208
    [No Abstract]   [Full Text] [Related]  

  • 25. Citalopram in patients with unsatisfactory response to neuroleptics: an open follow-up study.
    Syvälahti EK; Kallioniemi H; Lehto H
    Methods Find Exp Clin Pharmacol; 1994; 16(1):49-55. PubMed ID: 7909349
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects and side-effects of bromperidol in comparison with other antipsychotic drugs.
    Woggon B
    Acta Psychiatr Belg; 1978; 78(1):155-72. PubMed ID: 347878
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [First application of tablet form bromperidol in man with particular consideration of tolerance].
    Pöldinger W; Bures E
    Int Pharmacopsychiatry; 1978; 13 Suppl 1():26-9. PubMed ID: 35474
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical experience with pipothiazine palmitate (19552 R.P.) in hospitalized and open ward patients with functional psychoses.
    Salvesen C; Vaksdal K
    PDM; 1974; 5-6(9-12;1-8):10-4. PubMed ID: 4156935
    [No Abstract]   [Full Text] [Related]  

  • 29. A double-blind study of melperone and placebo in hospitalized chronic alcoholics in postintoxication phase.
    Carlsson C; Gullberg B; Höstery U; Christensson E
    Int J Clin Pharmacol Biopharm; 1979 Aug; 17(8):341-5. PubMed ID: 39900
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antipsychotic drug side effects: their relationship to dose.
    Kane JM
    J Clin Psychiatry; 1985 May; 46(5 Pt 2):16-21. PubMed ID: 2859276
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [7 years of experience with delayed action neuroleptics].
    Noguera Hosta R; Rendueles de Olmedo G
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1978; 6(3):293-8. PubMed ID: 31066
    [No Abstract]   [Full Text] [Related]  

  • 32. A clinical study with propericiazine in chronic psychotic patients.
    Deutsch M; Ananth JV; Ban TA
    Curr Ther Res Clin Exp; 1971 Jun; 13(6):353-8. PubMed ID: 4397391
    [No Abstract]   [Full Text] [Related]  

  • 33. Factors associated with reduction in antipsychotic medication dosage in adults with mental retardation.
    Luchins DJ; Dojka DM; Hanrahan P
    Am J Ment Retard; 1993 Jul; 98(1):165-72. PubMed ID: 8103998
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Zuclopenthixol acetate in viscoleo in acutely disturbed psychotic patients.
    Schlosberg A; Barr F
    Isr J Psychiatry Relat Sci; 1991; 28(2):60-3. PubMed ID: 1682290
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antipsychotic prescriptions in a university hospital outpatient population in Turkey: a retrospective database analysis, 2005-2006.
    Atik L; Erdogan A; Karaahmet E; Saracli O; Atasoy N; Kurcer MA; Balcioglu I
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 May; 32(4):968-74. PubMed ID: 18243462
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical evaluation of treatment of psychoses with once-a-day phenothiazine doses].
    Sidorowicz S; Krakiewicz A; Wilska M
    Psychiatr Pol; 1979; 13(3):251-6. PubMed ID: 38469
    [No Abstract]   [Full Text] [Related]  

  • 37. [Comparative research on some clinical and psychopharmacological parameters of reactive paranoid psychoses].
    Masiak M; Marmurowska-Michałowska H; Nagay J; Olajossy M; Perzyński J; Wysocka A
    Psychiatr Pol; 1993; 27(1):63-74. PubMed ID: 8098150
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Parenteral ziprasidone: a new atypical neuroleptic for emergency treatment of psychosis in Parkinson's disease?
    Oechsner M; Korchounov A
    Hum Psychopharmacol; 2005 Apr; 20(3):203-5. PubMed ID: 15799011
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pilot study on oxaflumazine, a new piperazinated phenothiazine].
    Villeneuve A; Dogan K; Lachance R; Drolet A
    Int J Clin Pharmacol; 1972 Aug; 6(3):246-55. PubMed ID: 4405378
    [No Abstract]   [Full Text] [Related]  

  • 40. Antipsychotic efficacy of fluotracen: a clinical trial.
    Levy MI; Kendler KS; Mathé AA; Mohs RC; Denigris Y; Trigos GG; Axiotis A; Rothpearl A; Davis KL
    J Clin Psychopharmacol; 1983 Jun; 3(3):189-92. PubMed ID: 6135723
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.